APA (7th ed.) Citation

Camon, A. M., Alonso, R., Muñoz, F. J., Cardozo, C., Bernal-Maurandi, J., Albiach, L., . . . Puerta-Alcalde, P. (2022). C-reactive protein cut-off for early tocilizumab and dexamethasone prescription in hospitalized patients with COVID-19. Scientific Reports, 12(1), 1. https://doi.org/10.1038/s41598-022-08882-x

Chicago Style (17th ed.) Citation

Camon, Ana M., et al. "C-reactive Protein Cut-off for Early Tocilizumab and Dexamethasone Prescription in Hospitalized Patients with COVID-19." Scientific Reports 12, no. 1 (2022): 1. https://doi.org/10.1038/s41598-022-08882-x.

MLA (9th ed.) Citation

Camon, Ana M., et al. "C-reactive Protein Cut-off for Early Tocilizumab and Dexamethasone Prescription in Hospitalized Patients with COVID-19." Scientific Reports, vol. 12, no. 1, 2022, p. 1, https://doi.org/10.1038/s41598-022-08882-x.